Vertex Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading provider of enterprise compliance technology for global commerce, today announced the release of new global research revealing that ...

Vertex Pharmaceuticals (VRTX) stock has moved lower recently, with the price down about 2% over the past month and roughly 8% ...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Senior Vice President Paul Negulescu has been named as one of the winners of this year’s Lasker~DeBakey ...

Vertex Pharmaceuticals said a new drug submission for its treatment for moderate to severe acute pain has been accepted for review by Health Canada. The biotechnology company said Thursday that the ...

Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

SAN DIEGO — For decades, the biotech industry has tried — and repeatedly failed — to develop new and effective painkillers without the addictive potential of opioids. But there’s reason to think that ...

Journavx revived an area of development long considered a graveyard. Can any other pain drugs keep investor excitement going?

Vertex is at a particularly important moment. The company has a multibillion-dollar cystic fibrosis business -- but it's advancing many other candidate programs in other indications. That may be a ...

WEST CHICAGO, IL, UNITED STATES, May 20, 2026 /EINPresswire.com/ -- Vertex Wireless, a leading technology distribution, ...

Vertex reported positive results from a phase 1 study of VX-880 in treating type 1 diabetes. There are some caveats with calling this drug a cure for type 1 diabetes. Vertex plans to advance another ...